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Subtle but widespread deficit in the cortical and subcortical grey matter is a consistent neuroimaging observation
in schizophrenia. Several studies have used voxel based
morphometry (VBM) to investigate the nature of this
structural deficit. We conducted a diagnostic test review
to explore the diagnostic potential of VBM in differentiating schizophrenia from other types of first-episode
psychoses.

Objectives
To determine whether VBM applied to the MRI brain
images can be used to differentiate schizophrenia from
other types of psychosis in participants who experience
first-episode psychosis.
Search Methods

Key words: morphometry/neuroanatomy/structural
MRI/diagnostic accuracy

In December 2013, we updated a previous search (May
2012) of MEDLINE, EMBASE, and PsycInfo using
OvidSP.

Background

Selection Criteria

Schizophrenia is a psychiatric disorder which involves
distortions in thought and perception, blunted affect,
and behavioral disturbances. The longer psychosis
goes unnoticed and untreated, the more severe the
repercussions for relapse and recovery. There is some
evidence that early intervention services can help, and
diagnostic techniques that could contribute to early
intervention may offer clinical utility in these situations. The index test being evaluated in this review
is the structural magnetic resonance imaging (MRI)
analysis technique known as voxel-based morphometry (VBM) that estimates the distribution of gray
matter tissue volume across several brain regions. This
review is an exploratory examination of the diagnostic
potential of VBM for use as an additional tool in the
clinical examination of patients with first-episode psychosis to establish whether an individual has a diagnosis of schizophrenia as opposed to other types of
psychosis.

We included retrospective and prospective studies that
consecutively or randomly selected adolescent and adult
participants (<45 years) with a first episode of psychosis;
and that evaluated the diagnostic accuracy of VBM for
differentiating schizophrenia from other psychoses compared with a clinical diagnosis made by a qualified mental
health professional, with or without the use of standard
operational criteria or symptom checklists. We excluded
studies in children, and in adult participants with organic
brain disorders or who were at high risk for schizophrenia, such as people with a genetic predisposition.
Data Collection and Analysis
Two review authors screened all references for inclusion.
We assessed the quality of studies using the QUADAS-2
instrument. Due to a lack of data, we were not able to
extract 2 × 2 data tables for each study nor undertake any
meta-analysis.
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Fig. 1. PRISMA diagram.

Main Results
We included 4 studies with a total of 275 participants with
first-episode psychosis. Diagnostic accuracy of VBM was
not evaluated in any of the studies, instead VBM was
used to quantify the magnitude of differences in gray
matter volume. Therefore, none of the included studies
reported data that could be used in the analysis, and we
summarized the findings narratively for each study (see
figure 1).
Authors’ Conclusions
There is no evidence to currently support diagnosing
schizophrenia (as opposed to other psychotic disorders)
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using the pattern of brain changes seen in VBM studies in
patients with first-episode psychosis. VBM has the potential to discriminate between diagnostic categories but the
methods to do this reliably are currently in evolution. In
addition, the lack of a direct evaluation of the use of VBM
to clinical practice in the studies to date limits the assessment of the diagnostic ability of VBM to differentiate
schizophrenia from other types of psychotic presentations.
Studies with an emphasis on statistical discrimination
approaches, using all of the brain-wide information collected from VBM studies, especially in first-episode populations with prospective diagnostic validation, need to be
conducted to realize the diagnostic potential of VBM (for
full details, please see Palaniyappan et al1).

